Clinical Stage T1c Prostate Cancer: Evaluation with Endorectal MR Imaging and MR Spectroscopic Imaging1
AUTOR(ES)
Zhang, Jingbo
FONTE
Radiological Society of North America
RESUMO
MR imaging findings may represent additional useful variables for predicting the disease extent in patients with clinically localized prostate cancer.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2770114Documentos Relacionados
- Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging
- Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging
- Are prostate carcinoma clinical stages T1C and T2 similar?
- Clinically low-risk prostate cancer: evaluation with transrectal doppler ultrasound and functional magnetic resonance imaging
- T2-weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy
